Literature DB >> 19468254

p16ink4a is a surrogate marker for high-risk and malignant cervical lesions in the presence of human papillomavirus.

S Lakshmi1, P Rema, Thara Somanathan.   

Abstract

OBJECTIVE: To strengthen the role of high-risk human papillomaviruses (HPVs) in the development of cervical cancer, and the association between HPV and the cell cycle inhibitor gene p16ink4a in cervical carcinogenesis.
METHODS: In this study, the association between p16ink4a and the presence of HPV DNA in cervical lesions was investigated in a total of 177 cervical biopsies classified as benign (n = 42), low-grade squamous intraepithelial lesions (LSIL; n = 34), high-grade squamous intraepithelial lesions (HSIL; n = 48) and invasive cancer (n = 53). p16ink4a expression was analyzed by immunohistochemistry while HPV DNA was localized by in situ hybridization.
RESULTS: No significant association was found between p16ink4a expression and HPV presence in benign and LSIL samples. In HSIL and invasive cancer, a significant association was found between p16ink4a overexpression and the presence of HPV DNA.
CONCLUSION: Immunohistochemical p16ink4a expression is associated with HPV infection in HSIL and cervical cancer, suggesting a role of p16 as a biomarker of HPV-associated cervical lesions. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19468254     DOI: 10.1159/000209392

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  8 in total

Review 1.  Human papillomavirus tumor infection in esophageal squamous cell carcinoma.

Authors:  Ethan B Ludmir; Sarah J Stephens; Manisha Palta; Christopher G Willett; Brian G Czito
Journal:  J Gastrointest Oncol       Date:  2015-06

2.  The prevalence of human papillomavirus in oral premalignant lesions and squamous cell carcinoma in comparison to cervical lesions used as a positive control.

Authors:  Miki Ishibashi; Mitsunobu Kishino; Sunao Sato; Eiichi Morii; Yuzo Ogawa; Katsuyuki Aozasa; Mikihiko Kogo; Satoru Toyosawa
Journal:  Int J Clin Oncol       Date:  2011-04-29       Impact factor: 3.402

Review 3.  Viral Pathogens in Oesophageal and Gastric Cancer.

Authors:  Kishen Rajendra; Prateek Sharma
Journal:  Pathogens       Date:  2022-04-15

4.  The Role of Proteomics in the Diagnosis and Treatment of Women's Cancers: Current Trends in Technology and Future Opportunities.

Authors:  Eun-Kyoung Yim Breuer; Mandi M Murph
Journal:  Int J Proteomics       Date:  2011-01-01

5.  Frequent high-risk HPV co-infections excluding types 16 or 18 in cervical neoplasia in Guadeloupe.

Authors:  Stanie Gaete; Aviane Auguste; Bernard Bhakkan; Jessica Peruvien; Cecile Herrmann-Storck; Youri Socrier; Abdoulaye Diedhiou; Jacqueline Deloumeaux
Journal:  BMC Cancer       Date:  2021-03-16       Impact factor: 4.430

6.  Significance of Combined Analysis of High-Risk Human Papillomaviruses Polymerized Chain Reaction Analysis and Immunohistochemical Expression of p16INK4A in Cervical Cancer in a Cohort of South-Indian Population.

Authors:  Thathapudi Sujatha; Surekha Mullapudi Venkata; Erukkambattu Jayashankar; Uday Kumar Putcha; Sandeep Kumar Koturu; Triveni Bhopal; Krishnaveni Neelala; Sanjeeva Kumari Chinta; Reji Manjunathan
Journal:  Cureus       Date:  2022-09-10

7.  Correlation of EGFR, pEGFR and p16INK4 expressions and high risk HPV infection in HIV/AIDS-related squamous cell carcinoma of conjunctiva.

Authors:  Anthony Mwololo; Joshua Nyagol; Emily Rogena; Willis Ochuk; Mary Kimani; Noel Onyango; Lorenzo Pacenti; Rosa Santopietro; Lorenzo Leoncini; Walter Mwanda
Journal:  Infect Agent Cancer       Date:  2014-02-26       Impact factor: 2.965

Review 8.  Human papillomavirus and gastrointestinal cancer: A review.

Authors:  Dania Bucchi; Fabrizio Stracci; Nicola Buonora; Giuseppe Masanotti
Journal:  World J Gastroenterol       Date:  2016-09-07       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.